DHCC(SZ:002065)2016-04-25 16:00Financial Performance - The company's operating revenue for 2015 was ¥5,629,416,583.02, representing an increase of 8.86% compared to 2014[21]. - The net profit attributable to shareholders for 2015 was ¥1,141,878,403.18, reflecting a growth of 9.94% year-over-year[21]. - The net profit after deducting non-recurring gains and losses decreased by 7.92% to ¥936,583,557.45 in 2015[21]. - The total assets at the end of 2015 reached ¥11,156,713,729.02, a 40.80% increase from the previous year[22]. - The net assets attributable to shareholders increased by 35.24% to ¥8,503,772,488.42 at the end of 2015[22]. - The basic earnings per share for 2015 was ¥0.7416, up 5.75% from the previous year[21]. - Total revenue for 2015 reached ¥5,629,416,583.02, representing an 8.86% increase from ¥5,171,048,660.00 in 2014[73]. - The financial insurance and medical industry accounted for ¥2,812,854,039.84, or 50.44% of total revenue, with an 8.11% year-over-year growth[74]. - Revenue from technical services increased by 15.90% to ¥1,234,637,511.80, contributing 22.14% to total revenue[74]. - The company's system integration revenue decreased by 4.49% to ¥2,833,171,906.52, making up 50.80% of total revenue[74]. - Non-main business income surged by 24,299.26% to ¥52,272,439.60, representing 0.93% of total revenue[74]. - The North China region generated ¥3,240,559,920.82 in revenue, accounting for 58.10% of total revenue, with an 8.24% increase from the previous year[76]. - The gross profit margin for the financial insurance and medical industry was 34.18%, with a year-over-year decrease of 0.99%[77]. Cash Flow and Investments - The company reported a negative net cash flow from operating activities of ¥34,556,857.73, worsening by 128.19% compared to 2014[21]. - Operating cash inflow totaled 6,364,484,443.14 yuan, a 36.14% increase compared to the previous year[88]. - Operating cash outflow increased by 36.43% to 6,399,041,300.87 yuan, leading to a net cash flow from operating activities of -34,556,857.73 yuan, a decrease of 128.19%[88]. - Investment cash inflow surged by 220.67% to 246,483,153.68 yuan, primarily due to stock transfers and increased dividends from investments[88]. - The total amount of raised funds used in the reporting period was 74.27 million yuan, with a cumulative usage of 97.64 million yuan[98]. - The company has utilized 69.12 million yuan of idle raised funds to supplement working capital, which was fully returned by July 29, 2015[101]. - The company has a remaining balance of 21,243.37 million yuan (including interest) from raised funds, which will be permanently used to supplement working capital[102]. Business Expansion and Strategic Initiatives - The company has expanded its business into cloud computing, big data, and IoT, focusing on innovative business models and upgrading existing software products[30]. - The company has signed cooperation framework agreements with several provincial and municipal governments to promote smart city projects[31]. - The company has established strategic partnerships with top IT firms such as IBM, HP, and Huawei, enhancing its competitive edge in key areas like smart cities and cloud computing[37]. - The company is actively expanding its market share in the financial insurance sector, focusing on both large and regional financial institutions[44]. - The company is focusing on emerging fields such as internet finance, healthcare, and education to establish new growth points for long-term development[34]. - The company has established a smart city initiative, forming a consortium with nearly 60 enterprises to promote urban development projects across multiple cities, focusing on public safety and smart services[58]. - The smart community business achieved coverage in 1,200 communities and over 1 million users in Tianjin, exceeding the 2015 business expansion plan with a signed contract amount of over 70 million yuan[59]. - The company signed nearly 40 key land and real estate information projects in cities such as Wuhan and Hefei, indicating rapid and sustainable development in the land and real estate sector[60]. Research and Development - Research and development (R&D) expenses amounted to 884,213,069.19 yuan, accounting for 15.71% of total revenue, with a year-on-year growth of 6.07%[86]. - The number of R&D personnel increased by 42.58% to 2,632, representing 37.43% of the total workforce[86]. - The company is investing in new product development, with an allocated budget of HKD 100 million for R&D in 2016[107]. - The company is focusing on the development of medical big data, establishing a medical big data coordination center to enhance data collection and analysis capabilities[151]. Market Risks and Challenges - The company faces potential market risks, R&D risks, merger integration risks, and human resource risks, which are detailed in the management discussion and analysis section[6]. - The company faces market risks due to increasing competition in the software industry, necessitating a focus on core business development and professional capabilities[159]. - The company is committed to improving its human resources strategy to attract and retain top talent amid rising costs and competitive pressures[163]. Corporate Governance and Compliance - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties during the reporting period[182]. - There were no significant accounting errors that required retrospective restatement during the reporting period[184]. - The company did not change its accounting policies, estimates, or methods compared to the previous year's financial report[183]. - The company has engaged Beijing Xinghua Accounting Firm for auditing services, with a fee of 1.1 million CNY, and has maintained this auditor for 15 consecutive years[186]. Shareholder Returns - The company reported a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on the equity distribution registration date[6]. - The proposed cash dividend for the 2015 fiscal year is 1.5 CNY per 10 shares, with a total distributable profit of 2,279,422,503.07 CNY[177]. - The cash dividends paid in 2014 and 2013 represented 22.06% and 19.07% of the net profit attributable to shareholders, respectively[173]. - The company has committed to ensuring that cash dividends will constitute at least 20% of the total profit distribution during significant capital expenditure phases[175].